Information about the rules and regulations that govern interactions between pharmaceutical, bioscience, medical device company, and other life sciences company interactions with physicians and other healthcare professionals. This includes information on the Sunshine Act, state laws, the PhRMA Code, and the AdvaMed Code on Ethical Interactions with Healthcare Professionals.
Pharma meetings may have weathered the recession, but keynoters opening the Pharmaceutical Meeting Management Forum in Philadelphia say more challenges are ahead, including increasing government oversight.
The Harvard Medical School’s Faculty of Medicine Committee on Conflicts of Interest issued a report last month on its review of the school’s 20-year-old COI policy. The policy, according to the report, seeks to reinforce the “essential principle...
The Accreditation Council for Continuing Medical Education’s Board of Directors voted at its July meeting to approve a revised process for handling complaints regarding ACCME-accredited providers. The revisions, which were proposed in an effort...
